Ignite Creation Date:
2024-05-05 @ 10:33 PM
Last Modification Date:
2024-10-26 @ 10:20 AM
Study NCT ID:
NCT01131364
Status:
TERMINATED
Last Update Posted:
2014-02-25
First Post:
2010-05-25
Brief Title:
Combination Therapy of F16IL2 and Doxorubicin in Solid Tumour Patients
Sponsor:
Philogen SpA
Organization:
Philogen SpA
Organization Data
Organization:
Philogen SpA
Class:
INDUSTRY
Study ID:
PH-F16IL2DOXO-0407
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Philogen SpA
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None